HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome.

AuthorsC M Harper, A G Engel
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 841 Pg. 203-6 (May 13 1998) ISSN: 0077-8923 [Print] United States
PMID9668241 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Receptors, Cholinergic
  • Quinidine
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Humans
  • Middle Aged
  • Myasthenia Gravis (drug therapy, genetics, physiopathology)
  • Point Mutation
  • Quinidine (adverse effects, therapeutic use)
  • Receptors, Cholinergic (genetics)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: